Literature DB >> 18975343

Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis.

Gaia Codolo1, Amedeo Amedei, Allen C Steere, Elena Papinutto, Andrea Cappon, Alessandra Polenghi, Marisa Benagiano, Silvia Rossi Paccani, Vittorio Sambri, Gianfranco Del Prete, Cosima Tatiana Baldari, Giuseppe Zanotti, Cesare Montecucco, Mario Milco D'Elios, Marina de Bernard.   

Abstract

OBJECTIVE: Human Lyme arthritis caused by Borrelia burgdorferi is characterized by an inflammatory infiltrate that consists mainly of neutrophils and T cells. This study was undertaken to evaluate the role of the innate and acquired immune responses elicited by the neutrophil-activating protein A (NapA) of B burgdorferi in patients with Lyme arthritis.
METHODS: Serum anti-NapA antibodies were measured in 27 patients with Lyme arthritis and 30 healthy control subjects. The cytokine profile of synovial fluid T cells specific for NapA was investigated in 5 patients with Lyme arthritis. The cytokine profile induced by NapA in neutrophils and monocytes was also investigated.
RESULTS: Serum anti-NapA antibodies were found in 48% of the patients with Lyme arthritis but were undetectable in the healthy controls. T cells from the synovial fluid of patients with Lyme arthritis produced interleukin-17 (IL-17) in response to NapA. Moreover, NapA was able to induce the expression of IL-23 in neutrophils and monocytes, as well as the expression of IL-6, IL-1beta, and transforming growth factor beta (TGFbeta) in monocytes, via Toll-like receptor 2.
CONCLUSION: These findings indicate that NapA of B burgdorferi is able to drive the expression of IL-6, IL-1beta, IL-23, and TGFbeta by cells of the innate immune system and to elicit a synovial fluid Th17 cell response that might play a crucial role in the pathogenesis of Lyme arthritis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18975343     DOI: 10.1002/art.23972

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  37 in total

1.  Treg cell numbers and function in patients with antibiotic-refractory or antibiotic-responsive Lyme arthritis.

Authors:  Shiqian Shen; Junghee J Shin; Klemen Strle; Gail McHugh; Xin Li; Lisa J Glickstein; Elise E Drouin; Allen C Steere
Journal:  Arthritis Rheum       Date:  2010-07

2.  Borrelia species induce inflammasome activation and IL-17 production through a caspase-1-dependent mechanism.

Authors:  Marije Oosting; Frank L van de Veerdonk; Thirumala-Devi Kanneganti; Patrick Sturm; Ineke Verschueren; Anneleen Berende; Jos W M van der Meer; Bart-Jan Kullberg; Mihai G Netea; Leo A B Joosten
Journal:  Eur J Immunol       Date:  2010-12-09       Impact factor: 5.532

Review 3.  [Th17 cells - a new proinflammatory T cell population and its role in rheumatologic autoimmune diseases].

Authors:  J Leipe; A Skapenko; H Schulze-Koops
Journal:  Z Rheumatol       Date:  2009-07       Impact factor: 1.372

4.  Infection of Interleukin 17 Receptor A-Deficient C3H Mice with Borrelia burgdorferi Does Not Affect Their Development of Lyme Arthritis and Carditis.

Authors:  Carrie E Lasky; Kara E Jamison; Darcie R Sidelinger; Carmela L Pratt; Guoquan Zhang; Charles R Brown
Journal:  Infect Immun       Date:  2015-05-04       Impact factor: 3.441

Review 5.  Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease.

Authors:  Zhan-Ju Liu; Praveen-K Yadav; Jing-Ling Su; Jun-Shan Wang; Ke Fei
Journal:  World J Gastroenterol       Date:  2009-12-14       Impact factor: 5.742

6.  Ixodes ricinus salivary serpin IRS-2 affects Th17 differentiation via inhibition of the interleukin-6/STAT-3 signaling pathway.

Authors:  Jana Páleníková; Jaroslava Lieskovská; Helena Langhansová; Michalis Kotsyfakis; Jindřich Chmelař; Jan Kopecký
Journal:  Infect Immun       Date:  2015-02-23       Impact factor: 3.441

7.  Elevated levels of IL-23 in a subset of patients with post-lyme disease symptoms following erythema migrans.

Authors:  Klemen Strle; Daša Stupica; Elise E Drouin; Allen C Steere; Franc Strle
Journal:  Clin Infect Dis       Date:  2013-11-11       Impact factor: 9.079

8.  Interleukin-10 (IL-10) inhibits Borrelia burgdorferi-induced IL-17 production and attenuates IL-17-mediated Lyme arthritis.

Authors:  Emily S Hansen; Velinka Medić; Joseph Kuo; Thomas F Warner; Ronald F Schell; Dean T Nardelli
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

9.  Dysregulation of CD4+CD25(high) T cells in the synovial fluid of patients with antibiotic-refractory Lyme arthritis.

Authors:  Nalini K Vudattu; Klemen Strle; Allen C Steere; Elise E Drouin
Journal:  Arthritis Rheum       Date:  2013-06

Review 10.  Th17 cytokines and arthritis.

Authors:  Erik Lubberts
Journal:  Semin Immunopathol       Date:  2010-02-04       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.